[Complete left lung atelectasis as the initial presentation of allergic bronchopulmonary aspergillosis: a case report].
This paper reports a case of allergic bronchopulmonary aspergillosis (ABPA) presenting with acute respiratory failure and complete left lung atelectasis on imaging. The patient had no prior history of respiratory disease and experienced a sudden onset of symptoms, with partial atelectasis of the left lung rapidly progressing to complete collapse. Significant clinical improvement was observed after bronchoscopic removal of a suspected "foreign body" from the left main bronchus, leading to an initial misdiagnosis of bronchial foreign body. However, one month later, follow-up imaging revealed a new shadow in the left upper lobe. Further investigation confirmed the diagnosis of ABPA caused by sensitization to <i>Aspergillus terreus</i>.The patient was treated with two courses of systemic corticosteroids combined with antifungal therapy, resulting in effective disease control. Over a six-year follow-up period, the patient maintained a favorable prognosis with no progression to late-stage pulmonary complications. Complete lung atelectasis-type ABPA poses significant diagnostic challenges in its early stages and remains rarely reported in the domestic literature, leading to a high risk of misdiagnosis or delayed diagnosis. This case report aims to raise clinical awareness and facilitate earlier recognition of this uncommon presentation among healthcare professionals.
Authors
- Aixue Hu (ORCID: https://orcid.org/0000-0002-1337-287X)
- Jianbao Dong (ORCID: https://orcid.org/0000-0003-0424-1525)
- Junzhe Jiao
- Qing Luo (ORCID: https://orcid.org/0000-0001-7559-5174)
- Wei Guan (ORCID: https://orcid.org/0000-0001-9935-7074)
- Guo Dai
Institutions
- Shenzhen Bao'an District People's Hospital (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-07-12
- DOI
- https://doi.org/10.3760/cma.j.cn112147-20250113-00032
- Primary Topic
- Tracheal and airway disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00